Literature DB >> 23267281

Can we afford the war on cancer?

Ed Silverman.   

Abstract

Immunotherapy vaccines could extend survival in a handful of cancers. But personalizing treatment, payers argue, is not sustainable. Where should the line be drawn?

Entities:  

Year:  2012        PMID： 23267281      PMCID： PMC3524749     

Source DB:  PubMed          Journal:  Biotechnol Healthc        ISSN： 1554-169X


  1 in total

1.  Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity.

Authors:  Yao Jiang; Nishta Krishnan; Jiarong Zhou; Sanam Chekuri; Xiaoli Wei; Ashley V Kroll; Chun Lai Yu; Yaou Duan; Weiwei Gao; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Mater       Date:  2020-06-15       Impact factor: 30.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.